Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment

about

Selective inhibition of matrix metalloproteinase-2 in the multiple myeloma-bone microenvironment

Item

http://www.wikidata.org/entity/Q38726989

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Selective inhibition of matrix ...... myeloma-bone microenvironment

@en

type

Item

label

Selective inhibition of matrix ...... myeloma-bone microenvironment

@en

prefLabel

Selective inhibition of matrix ...... myeloma-bone microenvironment

@en

P1476

Selective inhibition of matrix ...... myeloma-bone microenvironment

@en

P2093

Conor C Lynch

http://www.w3.org/2001/XMLSchema#string

Daniel M Sullivan

http://www.w3.org/2001/XMLSchema#string

Fulvio Loiodice

http://www.w3.org/2001/XMLSchema#string

Lori A Hazlehurst

http://www.w3.org/2001/XMLSchema#string

Marilena Tauro

http://www.w3.org/2001/XMLSchema#string

Paolo Tortorella

http://www.w3.org/2001/XMLSchema#string

P2860

Moving targets: Emerging roles for MMPs in cancer progression and metastasis

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer.

The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Matrix metalloproteinases

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials

Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

Transcriptome analysis reveals molecular profiles associated with evolving steps of monoclonal gammopathies.

An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.

Strategies for MMP inhibition in cancer: innovations for the post-trial era.

P304

41827-41840

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.18103

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gemma Shay

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28611279

http://www.w3.org/2001/XMLSchema#string

P932

5522031

http://www.w3.org/2001/XMLSchema#string